| # | % | |||||
|---|---|---|---|---|---|---|
| 301 | ISHARES TR | 3,053 | 380,000 | 0.02% | ||
| 302 | AVALANCHE BIOTECHNOLOGIES IN | 32,889 | 371,000 | 0.02% | ||
| 303 | Aldeyra Therapeutics Inc | 8,333 | 85,000 | 0.01% | ||
| 304 | TETRALOGIC PHARMA CO | 19,188 | 84,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-15-001259, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
